Abstract
1β-hydroxy alantolactone, a sesquiterpene lactone, exhibits potent anti-inflammatory and anticancer activities. Recently, it has been found to target UbcH5s by covalently bonding with Cys85 specifically, but the exact molecular basis remains unclear. Here, we analyzed the structural specificity of the catalytic site of UbcH5s by comparing them with other E2 proteins. Molecular dynamics was performed to detect the structural stability of the catalytic site. Docking method was then used to predict conformations of ligand docked at the catalytic site of UbcH5s. The electrostatic surface and charge distribution of ligand and proteins were analyzed by quantitative calculation. Molecular dynamics was used to detect the stability of docking complexes of 1β-hydroxy alantolactone and UbcH5s, the covalently bonded intermediates and the products. The QM/MM methodology was used to calculate the free energy barrier of hydrogen transfer and formation of covalent bond between 15-position carbon of ligand and Cys85. Results revealed that the structure of the catalytic site is stable, and 1β-hydroxy alantolactone can dock at the catalytic site with correct conformation. Molecular dynamics further demonstrates that 1β-hydroxy alantolactone can steadily combine with UbcH5s. Intermediate and product of catalytic reaction are also certified to be stable. Besides, Asp112 and Asn114 function as anchors to fix ligand, ensuring it steadily docked at catalytic site to complete covalent reaction. More importantly, we have found that Cys85 of UbcH5c is more efficient to form a covalent bond with the ligand in comparison with UbcH5a and UbcH5b. Our results successfully explained the mechanism of 1β-hydroxy alantolactone covalently bonding with UbcH5s. Such molecular mechanism may provide a better insight into the molecular development or modification for ubiquitin-related drugs.
Similar content being viewed by others
Introduction
Recent studies have indicated that medicinal herbs have been gradually widely used despite insufficient information correlating with their mechanism of action. At present, research institutions or companies are devoting themselves to discovery a class of bioactive compounds, their valuable target proteins and mechanisms of action against diseases. Sesquiterpene lactones are plant-derived bioactive constituents, which have subjected numerous studies. Researches revealed that they could be used in medicines against inflammation, cancer, malaria, and viral and bacterial infection1,2. Pharmacodynamic studies further reported that sesquiterpene lactones might exert therapeutic effects by inhibiting NF-κB and MAPK pathway activation3,4,5,6,7,8. Nevertheless, the molecular mechanism of sesquiterpene lactones targeting protein on NF-κB and MAPK pathway is unknown.
1β-hydroxy alantolactone that belonged to sesquiterpene lactone has been found to possess anti-inflammatory and anticancer activities. From the data of its discovery, studies reported almost the same pharmacological effects of 1β-hydroxy alantolactone and its derivatives9, of which they can covalently bond with Cys38 of p65, further influencing NF-κB signal pathway10,11,12. However, these results failed to explain whether 1β-hydroxy alantolactone has specific selectivity for Cys38, nor can it explain the mechanism of action between the ligand and the protein. Recently, Zhenlin Hu and Weidong Zhang team’s study13 found that 1β-hydroxy alantolactone can specifically establish covalent bonds with Cys85 of Ubiquitin-conjugating Enzyme H5 (UbcH5), preventing catalytic reaction and inhibiting effectively activation of TNF-α/NF-κB pathway (the pathway is shown in Fig. 1). Although preliminary docking simulation in their research has been performed, the exact molecular basis remains unclear. To modify the structure of 1β-hydroxy alantolactone and better develop this leading compound against UbcH5 in the treatment of inflammatory diseases, the specific mechanism of 1β-hydroxy alantolactone interacting with UbcH5s is needed to explore in-depth.
Ubiquitination is a hierarchical enzymatic cascade, during which a ubiquitin (Ub)-activating enzyme (E1) first activates Ub and transfers it to Ub-conjugating enzyme (E2), then E2 interacting with Ub ligase (E3) transfers Ub to the lysine residue of target proteins14. UbcH5s belonged to E2 enzymes are involved in TNF-α/NF-κB signaling pathway, consisting of three homologs‒UbcH5a, UbcH5b, and UbcH5c15. UbcH5s are proven to cooperate with c-IAPs to generate a linear polyUb chain on the NF-κB essential modifier (NEMO)16,17,18. Moreover, UbcH5s knockdown can significantly influence the ubiquitination of NEMO, IKK activation, and NF-κB-regulated gene transcription. Therefore, UbcH5s are essential protein modulating TNF-α/NF-κB activity, which might be a valid target in treating inflammation.
Molecular dynamics (MD) simulation is used to predict how every atom in a protein or other molecular system will move over time based on Newton’s physics19. These simulations can capture a wide variety of important biomolecular processes, including conformational change, ligand binding, and protein folding. Importantly, such simulations can also predict how biomolecules will respond—at an atomic level—to perturbations such as mutation, phosphorylation, protonation, or the addition or removal of a ligand. MD simulations are often used in combination with experimental structural biology techniques, including X-ray crystallography, cryoelectron microscopy (cryo-EM) and nuclear magnetic resonance (NMR). During MD simulations, a variety of properties, such as the flexibility of ligand or residues, hydrogen bonds, and hydrophobic property, can be analyzed through successive trajectories of molecular dynamics. According to these properties, explaining the mechanisms of ligand-protein interactions becomes possible. Up to now, this approach is widely applied in biomolecules and drug discovery20,21,22. However, the limitation for this force-field based simulations is the chemical reactivity, such as bond break or formation, which cannot be simulated during MD. To solve this problem, hybrid quantum mechanics/molecular mechanics (QM/MM) methods have been developed23. QM/MM methods combine a quantum mechanical treatment of the subset of atoms involved in the chemical reaction with a molecular mechanics description of the surroundings. Partitioning the system is based on the idea that the apparent redistribution of the electron is often limited to a small subset of the atoms, while the effects of the majority atoms in the system can be described adequately by a classical treatment of intermolecular interactions. Therefore, QM calculation with higher accuracy is applied to treat the formation of a covalent bond at the catalytic site, and a classical (MM) treatment is used for the surroundings in this research.
In this research, we utilized MD simulations and QM/MM calculations to describe comprehensively the reaction process of 1β-hydroxy alantolactone catalyzed by UbcH5s. Here, Cys85 is a conservative catalytic site and activated when thiol hydrogen transfers to Asp117. The activated Cys85 will undergo a nucleophilic attack on the carbon atom of α-methylene of the ligand and form a covalent bond with it. Asn114 and Asp112 are found to form stable hydrogen bonds with substrate to guarantee it combining firmly with protein at the active site. Besides, Cys85 of UbcH5c is more efficient to be activated and form a covalent bond with the ligand in comparison with UbcH5a and UbcH5b. 1β-hydroxy alantolactone might be more selective for UbcH5c. In this research, we explain the reaction mechanism of 1β-hydroxy alantolactone interacting with UbcH5s for the first time, hoping the information that could assist the modification of molecule and drug development against inflammation.
Results
Sequence alignment and structure superposition analysis
Human UbcH5s (UbcH5a24, UbcH5b25 and UbcH5c26) sequence alignment and structural superposition were performed using CLUSTALW27, ESPript 3.028 and PyMol 1.629 (as shown in Fig. 2A,B). According to alignment analysis, the homology of the three proteins is up to 99.8%, and the amino acid sequences of the three proteins are almost identical. The backbone atoms were used to compute structural superposition. The ΔRMSD of three superposed tertiary structures is 0.98 Å, indicating that the three-dimensional structure of the proteins is almost the same. Cys85 responsible for covalently binding with the substrate is conservative in all three proteins. Asp117 near 1.6–1.8 Å of Cys85 can be found, which can form Cys-Asp catalytic diad. Meanwhile, Cys85 can form a hydrogen bond with Asp117, and the hydrogen-bond distances are respective 2.1, 1.9 and 2.3 Å. However, the similar paired residues and the hydrogen bonds are not found in other E2 protein (as shown in Figure S1), suggesting that Cys85-Asp117 might be a unique catalytic diad in UbcH5s.
The structural formula of 1β-hydroxy alantolactone is shown in Fig. 2C, and we have put forward a catalytic mechanism of 1β-hydroxy alantolactone forming a covalent bond with UbcH5s, as shown in Fig. 2D. At the beginning of the catalysis, the strong hydrogen bond between Cys85 and Asp117 is formed, and the hydrogen-bond distance should be maintained stable (1). Then hydrogen of Cys85 thiol will transfer to carboxyl oxygen of Asp117, resulting in activation of Cys85. The activation of Cys85 will make a nucleophilic attack on the 15-position carbon of 1β-hydroxy alantolactone docked at the catalytic site (2). Subsequently, Cys85 will form a covalent bond with the ligand, and the electron will migrate to the 14-position oxygen of ligand because of the attraction of oxygen atoms to electrons. Simultaneously the 14-position carbonyl oxygen of ligand will form a hydrogen bond with the carboxy hydrogen of Asp117 (3). Finally, the hydrogen of Asp117 carboxyl should be transferred to the 14-position carbonyl oxygen of ligand, and the chemical double bond is rearranged. Asp117 should still form a hydrogen bond with the substrate when Michael’s addition reaction is completed (4).
Structural stability of catalytic site of UbcH5s
At the (1) step of the catalytic process, the 100 ns duration simulations were performed to detect whether the protein structures are stable during the simulation. The global structural stability of UbcH5s was evaluated using the RMSD of the backbone atoms (Fig. 3A). During the 100 ns simulation, RMSDs of UbcH5s fluctuate between 0.5 and 1.5 Å. The ΔRMSDs of UbcH5s are all less than 2 Å, which indicate the stability of structures throughout the simulation. In Fig. 3B, a superimposed analysis of backbone atoms between the initial and final configurations of UbcH5s for molecular dynamics was performed, and ΔRMSD < 1 Å. It is worth noting that the 3D positions of Cys85 and Asp117 in initial and final snapshots are almost entirely coincident, and there is not displacement observed. According to this analysis, the catalytic sites of UbcH5s are stable when the substrate not bound.
After the determination of global structural stability by RMSD, we performed a more detailed analysis of each amino acid in UbcH5s. As shown in Fig. 3C, RMSF was used to evaluate the flexibility of the residues. The RMSF values Cys85 and Asp117 are found to be at the bottom of the curve, which suggested that these two essential amino acids with small fluctuation are beneficial to the progress of the catalytic process.
In Fig. 3D, the distance between the carboxyl oxygen of Asp117 and thiol hydrogen of Cys85 is maintained at around 2.0 Å in UbcH5a, 2.4 Å in UbcH5b and 1.75 Å in UbcH5c. In comparison with UbcH5a and UbcH5b, the distance between Cys85 and Asp117 in UbcH5c is closer, suggesting that a stronger hydrogen bond might be formed.
Interactions between 1β-hydroxy alantolactone and UbcH5s
At the (2) step of the catalytic process, molecular docking techniques were used to predict the docking mode of 1β-hydroxy alantolactone to macromolecular partner, UbcH5s. The best matching conformations of ligands docked with activated catalytic sites of UbcH5s are shown in Fig. 4. Because of the covalent attachment of ligand and protein is Michael addition, electrostatic potential surfaces (ESP) of ligand and protein were analyzed firstly (as shown in Fig. 4A). The ESP of 15-position olefin carbon of ligand is 9 kJ/mol, in which atom is positively charged. The sulfur atom of Cys85 in the catalytic site is shown as negatively charged. This indicated that these two atoms can form electrostatic interactions, and subsequent docking poses could further reinforce this hypothesis. Figure 4B–D display the best docking pose of ligand, from which 1β-hydroxy alantolactone enables to dock at the catalytic site. The 15-position olefin carbon of ligand facing the sulfur atom of Cys85 and the distances between two atoms are respectively 3.691, 3.711 and 3.940 Å in UbcH5s. In addition, combining the 2D scheme of docking results, 1β-hydroxy alantolactone is detected to form hydrogen bonds with Asp112 and Asn114. The two crucial hydrogen bonds can enhance the ligand binding at the catalytic site. In Fig. 5, energy decomposition between ligand and around residues was performed to confirm again that 15-position carbon of ligand can still form strong electrostatic interaction with Cys85, and the interaction is not affected by surrounding residues.
Stability of docking complex system during molecular dynamics simulation
During the (2) step of the catalytic process, 100 ns MD simulations for ligand-UbcH5s complex were performed. RMSD values of the backbone atoms were calculated, as shown in Fig. 6A. The RMSD values of all complexes fluctuate between 0.4–1.0 Å, and ΔRMSDs of all complexes obviously is less than 2 Å. The result indicates that all complexes keep equilibrium during 100 ns simulation.
The analysis of RMSF (as shown in Fig. 6B) reveals that the values of Cys85, Asp112, Asn114 and Asp117 are at the bottom of the curve. According to the above docking results, Cys85, Asp112 and Asn114 can respectively form electrostatic interaction and hydrogen bonds with the ligand. Asp117 can form a hydrogen bond with Cys85. These residues that have minimal fluctuations are conducive to the immobilization of 1β-hydroxy alantolactone docked at the catalytic site.
In Fig. 6C–F, the distances between sulfur atom of Cys85 and hydroxyl hydrogen of Asp117 are probably maintained at 1.95, 2.00 and 1.95 Å; the 15-position carbon of ligand and sulfur atom of Cys85 are about 3.45, 3.77 and 3.67 Å; the distances between 16-position hydroxyl hydrogen of ligand and oxygen of Asp112 are around 1.6–2.1 Å; the distances between 13-position epoxy of ligand and amino hydrogen of Asn114 are about 2.45, 1.85 and 2.1 Å. These stable distance changes further prove that ligand can stably bind at the catalytic site.
As described above, Asp112 and Asn114 can respectively form hydrogen bonds with 16-position hydroxyl hydrogen and 13-position epoxy of ligand (as shown in Figure S2A), from which the number of hydrogen bonds is almost 2. During 100 ns simulation, the hydrophobic strength between ligand and UbcH5s is detected, and the values fluctuate from 6 to 9 (as shown in Figure S2B). More importantly, MM-PBSA per frame was calculated, and the bind-energy between ligand and UbcH5s is about −50 kJ/mol, −40 kJ/mol and −60 kJ/mol (as shown in Figure S2C). According to these results, ligand could be dock steadily at catalytic sites of UbcH5s.
Covalent bond formation and stability of complex system
At the (3) step of the catalytic process, we calculated the free energy barriers for 1β-hydroxy alantolactone covalently bonding with Cys85, and the 10 energy barriers for each UbcH5a/b/c system are showed in Figure S3A. From the initial substrate complex (ES) to transition state (TS), the energy barriers of UbcH5a are in the range of 80–100 kJ/mol, UbcH5b 70–85 kJ/mol and UbcH5c 67–77 kJ/mol. According to the calculated results, Savitzky–Golay30 method was used to generate the energy barrier curve, which can increase the precision of the data without distorting the signal tendency. As shown in Fig. 7A, the free energy barriers between ES and TS are respectively 83.22, 79.55 and 73.86 kJ/mol.
Due to the attraction of 14-position oxygen of ligand to electrons, the electric displacement has occurred. In order to determine our speculation, we have detected the distribution of electrons by calculating the Mulliken charge. As shown in Figure S4, the charge of 11-position carbon is respectively −0.165591, −0.170231 and −0.178964 in UbcH5a/b/c. The charge of 14-position oxygen is respectively −0.469924, −0.473256 and -0.496315 in UbcH5a/b/c. Combining with the analysis of free energy barriers, UbcH5c might be easier to accept hydrogen and complete electron transfer to Asp117.
Subsequently, molecular dynamics was used to detect the reliability and stability of the intermediates. The RMSD of all complexes fluctuates between 0.6–1.0 Å, and ΔRMSDs of all complexes obviously is less than 2 Å. The result shows that complexes keep equilibrium during 100 ns simulation (as shown in Fig. 7B). The RMSF analysis was performed to evaluate the flexibility of all residues (as shown in Fig. 7C). The fluctuations of Cys85, Asp112, Asn114 and Asp117 are still at the bottom of the curve, which reflects the stability of these residues. In Fig. 7D–F, the distances between the 14-position carbonyl oxygen of ligand and hydroxyl hydrogen of Asp117 are maintained at around 1.67, 1.88 and 1.99 Å, 16-position hydroxyl hydrogen and oxygen of Asp112 at 1.95, 1.85 and 1.95, and the 13-position epoxy and amino hydrogen of Asn114 at 2.24, 2.23 and 2.27 Å. The ligand is found to form hydrogen bonds with Asp112, Asn114 and Asp117. The hydrogen bonds content between these atoms almost maintains at around 3 (as shown in Figure S2D). The hydrophobic strength between ligand and UbcH5s are detected to change from 7 to 9 (as shown in Figure S2E). MM-PBSA per frame was calculated, and the bind-energy between ligand and UbcH5s is about −557 kJ/mol, −556 kJ/mol and −568 kJ/mol (as shown in Figure S2F). Since (3) step is an essential procedure that generates an intermediate, and the intermediate determines whether the catalytic speculation process is reasonable. According to the above results, the stability of the intermediate further verify our inferred reaction mechanism and confirms that our characterized transition state is meaningful.
Hydrogen atom transfer and stability of complex system
The (4) step of the catalytic process is the final procedure in which hydrogen should transfer from Asp117 to the 14-position carbonyl oxygen of ligand. The 10 free energy barriers of hydrogen transfer for each UbcH5a/b/c system are showed in Figure S3B. From the ES to TS, the energy barriers of UbcH5a are in the range of 28–31 kJ/mol, UbcH5b 28–30 kJ/mol and UbcH5c 25–29 kJ/mol. According to the calculated results, Savitzky–Golay method was used to generate energy barrier curves. As shown in Fig. 8A, the free energy barriers between ES and TS are respectively 30.21, 29.20 and 27.50 kJ/mol.
Then molecular dynamics was used to detect the reliability and stability of the products. The RMSDs of all complexes significantly raise, but ΔRMSDs of all complexes obviously is less than 2 Å, and all complexes keep equilibrium during 5–100 ns simulation (as shown in Fig. 8B). The RMSF values of Cys85, Asp112, Asn114 and Asp117 are still located at the bottom of the curve (as shown in Fig. 8C).
Figure 8D–F show the changes in distances between ligand and the above residues. The distances between the 14-position hydroxyl hydrogen of ligand and carbonyl oxygen of Asp117 are maintained probably at 1.95, 1.95 and 1.86 Å; the 16-position hydroxyl hydrogen of ligand and oxygen of Asp112 at 1.85, 1.85 and 1.95; and the 13-position epoxy of ligand and amino hydrogen of Asn114 at 2.35, 2.25 and 2.15 Å. The number of hydrogen bonds between the ligand and these atoms was analyzed (as shown in Figure S2G), from which the number of hydrogen bonds almost maintains at around 3. The hydrophobic strength between ligand and UbcH5s are detected to fluctuate from 6 to 9 (as shown in Figure S2H). The bind-energy between ligand and UbcH5s is about −535 kJ/mol, −538 kJ/mol and −545 kJ/mol (as shown in Figure S2I). These results prove the stability of the products and support our speculation for the mechanism at the (4) step.
Alanine scanning mutagenesis
Hot spots residues at the protein-ligand interfaces in all complexes of 1β-hydroxy alantolactone with UbcH5s were identified through ABS-Scan. The energetic contribution of each residue involved in the interaction with the protein and ligand was evaluated by AutoDock score (kJ/mol). We extracted dynamic trajectories for alanine-scanning simulation every 5 ns (as shown in Figure S5). Upon analysis, we found Cys85, Asp112 and Asn114 with lower energy compared with other residues involved in this mutation analysis. The curves of energy contribution demonstrate the importance of these three residues in catalyzing and immobilizing ligands again.
Conclusions
Ubiquitination plays an essential role in almost cellular process, such as cell-cycle progression, endocytosis and trafficking, and even immune-signal transduction31. TNF-α/NF-κB pathway has been reported to correlate with inflammatory diseases. UbcH5s are supported to play a pivotal role in TNF-α-mediated NF-κB activation by growing evidence18,32,33. 1β-hydroxy alantolactone since discovered is rarely reported about its pharmacological action, and only a few of literature indicated that it has anti-inflammatory effects. Apart from this, there is not a description in detail about its pharmacological mechanism. Although 1β-hydroxy alantolactone is discovered to form a covalent bond with UbcH5s13 effectively blocking the TNF-α/NF-κB pathway, molecular mechanism about it combined with UbcH5s was just preliminarily explored by docking method. In this research, we first elaborate how 1β-hydroxy alantolactone is covalently bonded to UbcH5s through hybrid methods including docking, MD simulations, and QM/MM calculations, which can provide the interaction mechanisms at the molecular level34.
Previous researches reported that Cys85 is the E2 active site residue, and it is able to form thiol bond with Ub from E125,35. Meanwhile, this residue participates in transducing the structural changes at the E3-binding site to the active site of UbcH536. Consistent with these findings, 1β-hydroxy alantolactone has been proved to covalently bond with cys85 of UbcH5s effectively suppressed protein activation. Therefore, we focused our attention on this residue in order to find out the mechanism of 1β-hydroxy alantolactone, specifically interacting with UbcH5s. In UbcH5s family, the sequences of UbcH5a/b/c are highly similar, and the 3D structure of these proteins almost coincide with each other. Therefore, we can assume that these proteins could perform similarity in behavior of catalysis. However, compared with other proteins such as Ubc1, Ubc7, UbcH7, UbcH8, Ube2b, Ube2j2, Ube2s, Ube2w, CDC34 and so forth, not only are there differences in sequences, but the protein structures are also vastly different. During analyzing the residues around Cys85 of UbcH5s, we found that Asp117 can form catalytic diad with Cys85. However, no Asp corresponding to Asp117 of UbcH5s is not detected in these proteins, in other word there is not Asp assisting Cys to complete catalytic reaction. This difference might be one of the reasons that 1β-hydroxy alantolactone can specifically target UbcH5s.
Because there are no obvious pocket areas on the protein surface for ligands docking, the binding poses to proteins are particularly important. Direct covalent docking experiment without judgment will make an unreasonable conformation. The research13 confirmed that 1β-hydroxy alantolactone can covalently modify the active site cysteine (Cys85) of UbcH5s. Therefore the ligand that could dock toward for Cys85 with correct conformation or not will determine the success or failure of the simulation experiment. We successfully obtained the pose of 15-position carbon of 1β-hydroxy alantolactone docked to Cys85 with proper orientation and distance. Moreover, the subsequent electrostatic surface analysis and energy decomposition further demonstrate the electrostatic interaction between sulfur atoms and carbon atoms. Such noncovalent interactions might serve as an initial site-recognition step when the ligand binds with UbcH5s. Then the probability of the covalent reaction and stability of the covalent adduct between ligand and Cys85 of UbcH5 should be raised.
Although molecular docking method successfully generated the suitable pose of 1β-hydroxy alantolactone interacting with UbcH5s, the conformation obtained by molecular docking is only a static result. Whether the structure can stably bind to the catalytic site over time requires further confirmation by molecular dynamics. In order to guarantee the scientific rationality of the simulation, we pay more attention to the stability of structures, residues and distances. In UbcH5s, a stable hydrogen-bond distance between the thiol of Cys85 and the carboxyl oxygen of Asp117 is beneficial to the deprotonation of Cys85 and activated Cys85 can attack the substrate nucleophilically. Therefore, we need to first evaluate the stability of the hydrogen bond distance between these two residues at the beginning of the entire simulation. Subsequently, activated Cys85 forms a covalent bond with the 15-position olefin carbon of the ligand, and the negatively charged ligand as an intermediate should form a hydrogen bond with Asp117 by 14-position oxygen atom. This hydrogen bond not only strengthens the intermediate but also to equilibrate the charge. Only stable intermediates can ensure the smooth progress of the catalysis, and it is also able to prove the correctness of our speculative reaction mechanism. When the catalytic process is completed, the 14-position carbonyl oxygen should be converted to a hydroxyl group and remains hydrogen bonding with Asp117, which can facilitate the stability of the covalently bound ligand at the catalytic site. In addition, Asp112 and Asn114 are found to form hydrogen bonds with 13-position epoxy and 16-position hydroxyl. These two hydrogen bonds are stable throughout the molecular dynamics. Since there are no obvious pockets or recessed areas on the surface of UbcH5s, hydrogen bonding plays a particularly important role in the process of ligand binding protein, and these hydrogen bonds are beneficial to fix ligand in the process of Michael addition. Molecular dynamics help us to confirm our assumption about the catalytic reaction mechanism further and dynamically describe the catalytic process in comparison with the direct covalently docking method.
Since molecular dynamics can only simulate the trajectories of atoms but not bond break or formation, therefore this problem is needed to be explored by quantum chemistry. The issue we are concerned about is whether the sulfur atom of Cys85 and the 15-position olefin carbon of ligand can form a covalent bond at such stable distances from 3.45 to 3.80 Å. According to calculated results, the free energy barriers for the covalent attachment of Cys85 to the substrate are respectively 83.22, 79.55 and 73.86 kJ/mol. In comparison with UbcH5a and UbcH5b, UbcH5c with lower free energy barrier can effectively form the covalent bond. The energy barriers of the carboxyl hydrogen of Asp117 transferring to the 14-position carbonyl oxygen of ligand are 30.21, 29.20 and 27.50 kJ/mol respectively. Compared with UbcH5a and UbcH5b, the hydrogen of UbcH5c with lower free energy barrier transfers from Asp117 to 14-position carbonyl oxygen. According to the above analysis, the order of activation efficiency and effectiveness of covalent reaction can be sorted as UbcH5c > UbcH5b > UbcH5a. Cys85 of UbcH5c is more efficient to be activated and form a covalent bond with the ligand. The result is consistent with Zhenlin Hu and Weidong Zhang team’s research which has reported selectivity of among UbcH5a, UbcH5b, and UbcH5c with apparent dissociation constants (KD) of 5.189 mM, 3.578 mM, and 2.577 mM, respectively. Therefore, we infer that 1β-hydroxy alantolactone is more selective for UbcH5c.
In summary, we provide an interpretation for the mechanism of 1β-hydroxy alantolactone covalently bonds with UbcH5s. During this research, several residues including Asp112, Asn114 and Asp117, are particularly important, not only assisting in fixing ligand but also ensuring completion of the catalytic reaction. We confirmed that the molecular geometry of 1β-hydroxy alantolactone and the chemical environment around the target thiol group is the essential factors determining the reactive selectivity of ligand toward Cys85 of UbcH5s. 1β-hydroxy alantolactone represents the basis for a potential new class of therapeutics for anti-TNF-α interventions. A better understanding of the molecular mechanism for the ligand interacting UbcH5s can provide essential information about the development of ubiquitin-related drugs.
Materials and Methods
Sequence and structural analysis
In this research, amino acid sequences were aligned and 3D structures of UbcH5a (PDB ID: 3PTF), UbcH5b (PDB ID: 3EB6) and UbcH5c (PDB ID: 1 × 23) were superimposed. In addition, Ube2S (PDB ID: 1ZDN), UbcH7 (PDB ID: 1C4Z), Ubc1 (PDB ID: 1TTE), UbcH8 (PDB ID: 1WZV), Ube2B (PDB ID: 2YB6), Ube2J2 (PDB ID: 2F4W), Ubc7 (PDB ID: 2AW7), Ube2W (PDB ID: 2A7L) and CDC34 (PDB ID: 3RZ3) were downloaded to analyze residues distribution around Cys which is corresponded to Cys85 of UbcH5s. The organism of 3EB6 is Homo sapiens and Xenopus laevis, and the sequence is the same between humans and xenopus.
Molecular docking
Autodock 4.237 with Lamarckian genetic algorithm (LGA)38 was employed for the docking mode selection due to its good performance of reproduction capability39,40. Before molecular docking, the activated UbcH5s proteins in (2) step of the protocol were used to dock with 1β-hydroxy alantolactone. PDB2PQR Version 2.1.141 was used to prepare proteins for the calculation of electrostatic potentials. Protonation states of ionizable side chains were obtained with the PROPKA 3.1 method42,43 implemented in the PDB2PQR server. AutoDockTools 1.5.644 was used to prepare charge of proteins and save proteins as pdbqt file. The 3D structure of 1β-hydroxy alantolactone was constructed by ChemDraw ultra 2.045, and VEGA ZZ 3.1.246 was used to calculate and add MOPAC charge to ligand. Avogadro-1.2.047 was utilized to optimize structure of 1β-hydroxy alantolactone with method of steepest descent and gradient descent. Then AutoDock Tools 1.5.6 prepared pdbqt file for subsequent docking program. The docking calculations were performed by locating a 40 × 40 × 40 points grid map and with a 0.375 Å grid point spacing which covered the catalytic sites. Each ligand was docked for 100 times to meet the demand of retrieving the top one docking poses.
Molecular dynamics and reaction modeling studies
In this study, we firstly constructed two systems, which respectively were inactivated UbcH5s systems (1) and activated UbcH5s docked with ligands systems (2). Molecular dynamics was performed using the GROMACS 5.1.4. Amber99sb Force Field and the tip3p water condition were selected during the topology process. In this research, the above two kinds of systems were placed in the box at least 1.0 nm from the box edge, and the box was defined as a cube. We performed energy minimization to reach the maximum force below 250 kJ/mol. Equilibrating the water around the protein was performed under 100 ps NVT followed by 100 ps NPT ensembles at 298 K. MD data was collected for 100 ns in the NPT ensemble at 298 K, and the GROMACS program was used to constrain the bonds involving hydrogen atoms, allowing for an integration interval of 2 fs. A cutoff 1.0 nm was used for long-range van der Waals energies, and the particle mesh Ewald method48 was used for computing electrostatic interactions. The non-bonded pair lists were updated every 0.010 ps. The coordinates were saved every 100 ps.
To detect free energy barrier of Cys85 of UbcH5s covalently bonded with 1β-hydroxy alantolactone, we extracted respectively 10 snapshots of the dynamical trajectory from UbcH5a/b/c systems every 10 ns in the (2) step. Then quantum mechanics-molecular mechanics (QM/MM) potential was employed to calculate the energy barrier. QM/MM calculations were performed in Gaussian 09 using the ONIOM electronic embedding scheme49. QM region contained the ligand, Cys85 and Asp117, which were treated at the DFT B3LYP/6–31 G(d) level50,51. The surroundings were treated with MM region at UFF level. In addition, Mulliken charge has also been calculated to detect the electronic displacement. Then intermediates were used to MD simulation. The paraments of MD were consistent with the above dynamical description.
At the (03) step, the conformations of sulfur atom of Cys85 covalently bonded with ligands were used to MD simulation, and the paraments of MD were consistent with the above dynamical description. After 100 ns simulation, we extracted respectively 10 conformations from the dynamical trajectory of UbcH5a/b/c systems every 10 ns for the subsequent QM/MM calculation.
Gaussian 09 using the ONIOM electronic embedding scheme was performed to calculate QM/MM. Ligands, Cys85s and Asp117s included in QM region were treated at the DFT B3LYP/6–31 G(d) level. The surroundings of complexes were treated as MM region at UFF level. At (4) step, the calculated products sourced from 100 ns conformation were used for subsequent molecular dynamics. And paraments of MD was consistent with the above dynamical description.
Alanine scanning mutagenesis
To evaluate the vital role played by the hotspot residues of UbcH5s interacting with 1β-hydroxy alantolactone, the snapshots of each complex every 5 ns were extracted to Alanine scanning mutagenesis by using the ABS-Scan web server for protein–ligand alanine scanning52. To visualize the contribution of each residue interacting with ligand, each mutated structure will be scored by using the empirical scoring function of AutoDock53.
Data analysis
When the simulation was completed, the trajectories of each system were concatenated for analysis. PyMol (www.pymol.org) YASARA View54 and VMD 1.9.355 were used to create images. All electrostatic surfaces were calculated using Multiwfn 3.756 and images were rendered using PyMol and VMD 1.9.3. Multiple sequence alignments were performed using CLUSTALW and further analyses were performed using ESPript 3.057. Root-mean-square deviation (RMSD) and root mean square fluctuation (RMSF) of backbone heavy atoms with respect to their initial structure were calculated every 100 ps. In the catalytic site, several distances between Cys85 and Asp117, ligand and Asp112, ligand and Asp117 and ligand and Asn114 were analyzed by using Gromacs. Binding energies were calculated by using the MM-PBSA tool as described by Kumari et al.58, utilizing APBS59 to solve Possion-Boltzman equations. The extensive details have been described in the paper and on the web (http://rashmikumari.github.io/g_mmpbsa/accessed.21040920). In addition, hydrogen bond changes between ligand and protein, hydrophobic strength between ligand and protein were also analyzed by Gromacs.
References
Wang, G. W. et al. Inula sesquiterpenoids: structural diversity, cytotoxicity and anti-tumor activity. Expert Opin Investig Drugs. 23(3), 317–345, https://doi.org/10.1517/13543784.2014.868882 PMID: 24387187 (2014).
Zaima, K. et al. Isoheleproline: a new amino acid-sesquiterpene adduct from Inula helenium. J Nat Med. 68(2), 432–435, https://doi.org/10.1007/s11418-013-0806-8 PMID: 24198124 (2014).
Ren, Y. et al. Cytotoxic and NF-kappaB inhibitory sesquiterpene lactones from Piptocoma rufescens. Tetrahedron. 68(12), 2671–2678, https://doi.org/10.1016/j.tet.2012.01.061 PMID: 22685350 (2012).
Babaei, G., Aliarab, A., Abroon, S., Rasmi, Y. & Aziz, S. G. Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity. Biomed Pharmacother. 106, 239–246, https://doi.org/10.1016/j.biopha.2018.06.131 PMID: 29966966 (2018).
Zhao, Y. et al. Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-kappaB-dependent mechanism. Oxid Med Cell Longev. 2015, 934058, https://doi.org/10.1155/2015/934058 PMID: 25664142 (2015).
Formisano, C. et al. Anti-inflammatory sesquiterpene lactones from Onopordum illyricum L. (Asteraceae), an Italian medicinal plant. Fitoterapia. 116, 61–65, https://doi.org/10.1016/j.fitote.2016.11.006 PMID: 27871974 (2017).
Wang, Q. et al. Total sesquiterpene lactones isolated from Inula helenium L. attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice. Phytomedicine. 46, 78–84, https://doi.org/10.1016/j.phymed.2018.04.036 PMID: 30097125 (2018).
Gao, S. et al. Total sesquiterpene lactones prepared from Inula helenium L. has potentials in prevention and therapy of rheumatoid arthritis. J Ethnopharmacol. 196, 39–46, https://doi.org/10.1016/j.jep.2016.12.020 PMID: 27988396 (2017).
Garcia-Pineres, A. J. et al. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem. 276(43), 39713–39720, https://doi.org/10.1074/jbc.M101985200 PMID: 11500489 (2001).
Tang, J. J. et al. Diversity Modification and Structure-Activity Relationships of Two Natural Products 1beta-hydroxy Alantolactone and Ivangustin as Potent Cytotoxic Agents. Sci Rep. 8(1), 1722, https://doi.org/10.1038/s41598-018-20192-9 PMID: 29379131 (2018).
Amslinger, S. The tunable functionality of alpha,beta-unsaturated carbonyl compounds enables their differential application in biological systems. ChemMedChem. 5(3), 351–356, https://doi.org/10.1002/cmdc.200900499 PMID: 20112330 (2010).
Chen, L. et al. Semisynthesis, an Anti-Inflammatory Effect of Derivatives of 1beta-Hydroxy Alantolactone from Inula britannica. Molecules. 22(11), https://doi.org/10.3390/molecules22111835 PMID: 29077042 (2017).
Liu, L. et al. A sesquiterpene lactone from a medicinal herb inhibits proinflammatory activity of TNF-alpha by inhibiting ubiquitin-conjugating enzyme UbcH5. Chem Biol. 21(10), 1341–1350, https://doi.org/10.1016/j.chembiol.2014.07.021 PMID: 25200604 (2014).
Pickart, C. M. & Eddins, M. J. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta. 1695(1–3), 55–72, https://doi.org/10.1016/j.bbamcr.2004.09.019 PMID: 15571809 (2004).
Jensen, J. P., Bates, P. W., Yang, M., Vierstra, R. D. & Weissman, A. M. Identification of a family of closely related human ubiquitin conjugating enzymes. J Biol Chem. 270(51), 30408–30414, https://doi.org/10.1074/jbc.270.51.30408 PMID: 8530467 (1995).
Kirisako, T. et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25(20), 4877–4887, https://doi.org/10.1038/sj.emboj.7601360 PMID: 17006537 (2006).
Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol. 11(2), 123–132, https://doi.org/10.1038/ncb1821 PMID: 19136968 (2009).
Dynek, J. N. et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29(24), 4198–4209, https://doi.org/10.1038/emboj.2010.300 PMID: 21113135 (2010).
Karplus, M. & McCammon, J. A. Molecular dynamics simulations of biomolecules. Nat Struct Biol. 9(9), 646–652, https://doi.org/10.1038/nsb0902-646 PMID: 12198485 (2002).
Zuvela, P. et al. Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes. J Enzyme Inhib Med Chem. 33(1), 1430–1443, https://doi.org/10.1080/14756366.2018.1511551 PMID: 30220229 (2018).
Barril, X. & Luque, F. J. Molecular simulation methods in drug discovery: a prospective outlook. J Comput Aided Mol Des. 26(1), 81–86, https://doi.org/10.1007/s10822-011-9506-1 PMID: 22160626 (2012).
Aci-Seche, S., Ziada, S., Braka, A., Arora, R. & Bonnet, P. Advanced molecular dynamics simulation methods for kinase drug discovery. Future Med Chem. 8(5), 545–566, https://doi.org/10.4155/fmc.16.9 PMID: 27054816 (2016).
van der Kamp, M. W. & Mulholland, A. J. Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology. Biochemistry. 52(16), 2708–2728, https://doi.org/10.1021/bi400215w PMID: 23557014 (2013).
Bosanac, I., et al. Modulation of K11-linkage formation by variable loop residues within UbcH5A. J Mol Biol. 408(3), 420–431, https://doi.org/10.1016/j.jmb.2011.03.011 PMID: 21396940 (2011).
Mace, P. D., et al. Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. J Biol Chem. 283(46), 31633–31640, https://doi.org/10.1074/jbc.M804753200 PMID: 18784070.
Wu, F., Zhu, J., Li, H. & Zhu, L. Structural analysis of recombinant human ubiquitin-conjugating enzyme UbcH5c. Acta Pharm Sin B. 7(3), 390–394, https://doi.org/10.1016/j.apsb.2016.12.008 PMID: 28540177 (2017).
Thompson, J. D, Higgins, D. G, Gibson, T. J. & Clustal W. improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22(22), 4673–4680, https://doi.org/10.1093/nar/22.22.4673 PMID: 7984417 (1994).
Gouet, P., Courcelle, E., Stuart, D. I. & Metoz, F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics. 15(4), 305–308, https://doi.org/10.1093/bioinformatics/15.4.305 PMID: 10320398 (1999).
DeLano, W.: The PyMOL Molecular Graphics System. DeLano Scientific; San Carlos, CA, USA: 2002. In (2002).
Larive, C. K & Sweedler, J. V. Celebrating the 75th anniversary of the ACS Division of Analytical Chemistry: a special collection of the most highly cited analytical chemistry papers published between 1938 and 2012. Anal Chem. 85(9), 4201–4202, https://doi.org/10.1021/ac401048d PMID: 23647149 (2013).
Jaffray, E. G, Hay, R. T. Detection of modification by ubiquitin-like proteins. Methods. 38(1), 35–38, https://doi.org/10.1016/j.ymeth.2005.07.020 PMID: 16343933 (2006).
Bianchi, K, Meier, P. A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling. Mol Cell. 36(5), 736–742, https://doi.org/10.1016/j.molcel.2009.11.029 PMID: 20005838 (2009).
Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell. 136(6), 1098–1109, https://doi.org/10.1016/j.cell.2009.03.007 PMID: 19303852 (2009).
Liu, H. & Yao, X. Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation. Mol Pharm. 7(1), 75–85, https://doi.org/10.1021/mp900131p PMID: 19883112 (2010).
Ozkan, E., Yu, H. & Deisenhofer, J. Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases. Proc Natl Acad Sci USA 102(52), 18890–18895, https://doi.org/10.1073/pnas.0509418102 PMID: 16365295 (2005).
Lester, D., Farquharson, C., Russell, G. & Houston, B. Identification of a family of noncanonical ubiquitin-conjugating enzymes structurally related to yeast UBC6. Biochem Biophys Res Commun. 269(2), 474–480, https://doi.org/10.1006/bbrc.2000.2302 PMID: 10708578 (2000).
Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 30(16), 2785–2791, https://doi.org/10.1002/jcc.21256 PMID: 19399780 (2009).
Fuhrmann, J., Rurainski, A., Lenhof, H. P. & Neumann, D. A new Lamarckian genetic algorithm for flexible ligand-receptor docking. J Comput Chem. 31(9), 1911–1918, https://doi.org/10.1002/jcc.21478 PMID: 20082382 (2010).
Sun, H. Y., Ji, F. Q., Fu, L. Y., Wang, Z. Y. & Zhang, H. Y. Structural and energetic analyses of SNPs in drug targets and implications for drug therapy. J Chem Inf Model. 53(12), 3343–3351, https://doi.org/10.1021/ci400457v PMID: 24304102 (2013).
Sun, H. Y., Hou, T. J. & Zhang, H. Y. Finding chemical drugs for genetic diseases. Drug Discov Today. 19(12), 1836–1840, https://doi.org/10.1016/j.drudis.2014.09.013 PMID: 25256778 (2014).
Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32(Web Server issue), W665–667, https://doi.org/10.1093/nar/gkh381 PMID: 15215472 (2004).
Sondergaard, C. R., Olsson, M. H., Rostkowski, M. & Jensen, J. H. Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. J Chem Theory Comput. 7(7), 2284–2295, https://doi.org/10.1021/ct200133y PMID: 26606496 (2011).
Olsson, M. H., Sondergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. J Chem Theory Comput. 7(2), 525–537, https://doi.org/10.1021/ct100578z PMID: 26596171 (2011).
Sanner, M. F. Python: a programming language for software integration and development. J Mol Graph Model. 17(1), 57–61 PMID: 10660911 (1999).
Ultra C. 12.0, Cambridge Soft, Cambridge, MA 2010. Received: May, 10 PMID (2013).
Pedretti, A., Villa, L. & Vistoli, G. VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model. 21(1), 47–49, https://doi.org/10.1016/s1093-3263(02)00123-7 PMID: 12413030 (2002).
Hanwell M. D. et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 4(1), 17, https://doi.org/10.1186/1758-2946-4-17 PMID: 22889332 (2012)
Essmann, U. et al. A smooth particle mesh Ewald method. The Journal of chemical physics. 103(19), 8577–8593 (1995).
Frisch, M. J. et al. Gaussian 16 Rev. C.01. In. Wallingford, C. T (2016).
Lee, C., Yang, W. & Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter. 37(2), 785–789, https://doi.org/10.1103/physrevb.37.785 PMID: 9944570. 1988
Garrett, E. C. & Serianni, A. S. Ab initio molecular orbital calculations on furanose sugars: a study with the 6-31G basis set. Carbohydr Res. 206(2), 183–191, https://doi.org/10.1016/0008-6215(90)80059-c PMID: 2073631 (1990).
Anand, P., Nagarajan, D., Mukherjee, S. & Chandra, N. ABS-Scan: In silico alanine scanning mutagenesis for binding site residues in protein-ligand complex. F1000Res. 3, 214, https://doi.org/10.12688/f1000research.5165.2 PMID: 25685322 (2014).
Huey, R., Morris, G. M., Olson, A. J. & Goodsell, D. S. A semiempirical free energy force field with charge-based desolvation. J Comput Chem. 28(6), 1145–1152, https://doi.org/10.1002/jcc.20634 PMID: 17274016 (2007).
Krieger, E. & Vriend, G. YASARA View - molecular graphics for all devices - from smartphones to workstations. Bioinformatics. 30(20), 2981–2982, https://doi.org/10.1093/bioinformatics/btu426 PMID: 24996895 (2014).
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J Mol Graph. 14(1), 33–38, 27–38 PMID: 8744570 (1996).
Lu, T. & Chen, F. Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem. 33(5), 580–592, https://doi.org/10.1002/jcc.22885 PMID: 22162017 (2012).
Robert, X & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42(Web Server issue), W320–324, https://doi.org/10.1093/nar/gku316 PMID: 24753421 (2014).
Kumari, R. & Kumar, R., Open Source Drug Discovery C, Lynn A. g_mmpbsa–a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 54(7), 1951–1962, https://doi.org/10.1021/ci500020m PMID: 24850022 (2014).
Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA; 98(18), 10037–10041, https://doi.org/10.1073/pnas.181342398 PMID: 11517324 (2001).
Acknowledgements
This work was financially supported by the National Natural Science Foundation of China (No. 81773974)
Author information
Authors and Affiliations
Contributions
Youdong Xu completed the molecular simulation and wrote the main manuscript text. Xianli Meng reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xu, Y., Meng, X. Molecular Simulation Elaborating the Mechanism of 1β-Hydroxy Alantolactone Inhibiting Ubiquitin-Conjugating Enzyme UbcH5s. Sci Rep 10, 141 (2020). https://doi.org/10.1038/s41598-019-57104-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-57104-4
- Springer Nature Limited
This article is cited by
-
Promising Schiff bases in antiviral drug design and discovery
Medicinal Chemistry Research (2023)
-
Reading and erasing of the phosphonium analogue of trimethyllysine by epigenetic proteins
Communications Chemistry (2022)